I like your numbers but the reality will be different (imo). GNBT valuation is unknown and I wouldn't count on any substantial pps increase with confirmed 0 revenue and close to 120 M shares. In addition the gofund is turning into another joke and joining the NUGX fiasco. The same President/CEO/Chairman of the board is running both companies just to control any incoming funds. If the vaccine is successful run up one symbol , I doubt if two will benefit GNBT .......in addition GNBT will probably slaughter NGUX by selling shares..........initial projected GNBT shares were 69M including unforeseen circumstances effecting "your" dividend......
To clean up debt/lawsuits/paying bills etc another 50M dilution. And to top it off the potential IPO $$$$/PPS will most likely be protected by restricted shares .............